LUCY vs. BDMD, FEMY, NXGL, RVP, NRXS, ALUR, PETV, CLGN, NXL, and IRIX
Should you be buying Innovative Eyewear stock or one of its competitors? The main competitors of Innovative Eyewear include Baird Medical Investment (BDMD), Femasys (FEMY), NexGel (NXGL), Retractable Technologies (RVP), NeurAxis (NRXS), Allurion Technologies (ALUR), PetVivo (PETV), CollPlant Biotechnologies (CLGN), Nexalin Technology (NXL), and IRIDEX (IRIX). These companies are all part of the "medical equipment" industry.
Innovative Eyewear vs. Its Competitors
Baird Medical Investment (NASDAQ:BDMD) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, analyst recommendations, media sentiment, earnings, profitability, valuation and dividends.
19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 6.4% of Innovative Eyewear shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Baird Medical Investment has a beta of -0.94, indicating that its share price is 194% less volatile than the S&P 500. Comparatively, Innovative Eyewear has a beta of 3.22, indicating that its share price is 222% more volatile than the S&P 500.
In the previous week, Baird Medical Investment and Baird Medical Investment both had 2 articles in the media. Innovative Eyewear's average media sentiment score of 0.95 beat Baird Medical Investment's score of 0.63 indicating that Innovative Eyewear is being referred to more favorably in the news media.
Baird Medical Investment has higher earnings, but lower revenue than Innovative Eyewear.
Baird Medical Investment has a net margin of 0.00% compared to Innovative Eyewear's net margin of -443.18%. Baird Medical Investment's return on equity of 0.00% beat Innovative Eyewear's return on equity.
Summary
Baird Medical Investment beats Innovative Eyewear on 5 of the 8 factors compared between the two stocks.
Get Innovative Eyewear News Delivered to You Automatically
Sign up to receive the latest news and ratings for LUCY and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding LUCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Innovative Eyewear Competitors List
Related Companies and Tools
This page (NASDAQ:LUCY) was last updated on 7/16/2025 by MarketBeat.com Staff
